
    
      PRIMARY OBJECTIVE:

      I. To assess feasibility of a pilot randomized trial evaluating stereotactic ablative
      radiotherapy (SABR) and high-dose rate brachytherapy for localized prostate cancer.

      OUTLINE: Patients are randomized to 1 of 2 arms.

      ARM I: Patients undergo high-dose rate brachytherapy (HDR).

      ARM II: Patients undergo SABR every other day for 5 treatments.

      After completion of study treatment, patients are followed up periodically.
    
  